Curran Simpson

Insider Reports History

Location
Rockville, MD
Signature
/s/ Patrick J. Christmas as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Curran Simpson:

Company Role Class Num Shares Value Price $ Report Date Ownership
REGENXBIO Inc. Chief Executive Officer, Director Common Stock 342,467 $4,931,559 $14.40 06 Jan 2026 Direct
REGENXBIO Inc. Chief Executive Officer, Director Stock Options (Right to buy) 233,651 06 Jan 2026 Direct

Insider Reports Filed by Curran Simpson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RGNX REGENXBIO Inc. 06 Jan 2026 2 $0 4 Chief Executive Officer, Director 08 Jan 2026, 16:43
RGNX REGENXBIO Inc. 02 Jan 2026 1 -$267,250 4 Chief Executive Officer, Director 06 Jan 2026, 16:32
RGNX REGENXBIO Inc. 09 Oct 2025 1 -$262,635 4 Chief Executive Officer, Director 10 Oct 2025, 18:38
RGNX REGENXBIO Inc. 29 Sep 2025 1 -$76,469 4 Chief Executive Officer, Director 01 Oct 2025, 17:02
RGNX REGENXBIO Inc. 10 Sep 2025 1 -$77,495 4 Chief Executive Officer, Director 12 Sep 2025, 16:30
RGNX REGENXBIO Inc. 01 Jul 2025 1 -$38,689 4 Chief Executive Officer, Director 03 Jul 2025, 18:53
RGNX REGENXBIO Inc. 02 Jan 2025 1 $0 4/A Chief Executive Officer, Director 14 Jan 2025, 17:19
RGNX REGENXBIO Inc. 01 Aug 2024 1 -$1,500 4 Chief Executive Officer, Director 05 Aug 2024, 18:39
RGNX REGENXBIO Inc. 29 Jul 2024 1 -$145,106 4 Chief Executive Officer, Director 30 Jul 2024, 17:01
RGNX REGENXBIO Inc. 01 Jul 2024 2 $0 4 Chief Executive Officer, Director 03 Jul 2024, 07:56
RGNX REGENXBIO Inc. 02 Jan 2024 3 -$145,754 4 Chief Oper. & Tech. Officer 04 Jan 2024, 16:34
RGNX REGENXBIO Inc. 03 Jan 2023 3 -$47,084 4 Chief Oper. & Tech. Officer 05 Jan 2023, 15:06
RGNX REGENXBIO Inc. 01 Jan 2022 3 -$43,556 4 Chief Oper. & Tech. Officer 04 Jan 2022, 20:06